John Paul Secrist

3.8k citations
30 papers · 3.3k · 2 hit papers · h-index 24

Impact in

    • Histone Deacetylase Inhibitors Research
    • Protein Degradation and Inhibitors
    • Epigenetics and DNA Methylation
    • Cell death mechanisms and regulation
    • Ubiquitin and proteasome pathways
  • Hematology top 5%
    • Acute Myeloid Leukemia Research

Papers in

    • Histone Deacetylase Inhibitors Research 17
    • Protein Degradation and Inhibitors 10
    • Cell death mechanisms and regulation 4
    • Protein Kinase Regulation and GTPase Signaling 4
    • Ubiquitin and proteasome pathways 4
    • Biochemical and Molecular Research 2
    • Peptidase Inhibition and Analysis 8

John Paul Secrist

30 papers receiving 3.2k citations

John Paul Secrist's Hit Papers

Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia 2018 · 415 citations
4150+7+14Years since publication250500750

Peers

John Paul Secrist
Comparison fields: 5 of 101
  • Molecular Biology 2.5k
  • Hematology 384
  • Oncology 754
  • Immunology 558
  • Physiology 84
Replace Rooha Contractor with:
Rooha Contractor United States
Baole Wang United States
Shi-Chung Ng United States
Cherrie K. Donawho United States
Christopher J. Molloy United States
Brian Metcalf United States
Rónán C. O’Hagan United States
Michael J. Munchhof United States
Chris Tse United States
Matthew Robert Janes United States
John Paul Secrist relative to Rooha Contractor United States Rooha Contractor's profile →
Citations per field
00.5×2×3.1×
Rooha Contractor · 1×
Citations per year

Countries citing papers authored by John Paul Secrist

Since Specialization
Citations

This map shows the geographic impact of John Paul Secrist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Paul Secrist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Paul Secrist more than expected).

Fields of papers citing papers by John Paul Secrist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Paul Secrist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Paul Secrist. The network helps show where John Paul Secrist may publish in the future.

Co-authors

The 25 scholars most cited alongside John Paul Secrist, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Paul Secrist Line = papers co-authored together John Paul Secrist links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase I Study of an Oral Histone Deacetylase Inhibitor, Suberoylanilide Hydroxamic Acid, in Patients With Advanced Cancer
Hit paper breakdown →
2005801
2
Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia
Hit paper breakdown →
2018415
3 2007406
4 1993290
5 1991190
6 2007167
7 2008124
8 199897
9 202186
10 200784
11 199082
12 202057
13 201949
14 199546
15 201846
16 201343
17 199242
18 200742
19 200838
20 200837

About John Paul Secrist

John Paul Secrist is a scholar working on Molecular Biology, Oncology, Hematology, Immunology and Cancer Research, having authored 30 papers that have together received 3.3k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (17 papers), Protein Degradation and Inhibitors (10 papers), Peptidase Inhibition and Analysis (8 papers), Cell death mechanisms and regulation (4 papers), Protein Kinase Regulation and GTPase Signaling (4 papers), Ubiquitin and proteasome pathways (4 papers), Acute Myeloid Leukemia Research (3 papers) and Biochemical and Molecular Research (2 papers). The work is most often cited by research in Molecular Biology (2.5k citations), Hematology (384 citations), Oncology (754 citations), Immunology (558 citations) and Physiology (84 citations). John Paul Secrist has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Robert T. Abraham, Larry M. Karnitz, Victoria M. Richon, Gary A. Koretzky, Leigh Ann Burns, William Kevin Kelly, Paul A. Marks, Lee M. Krug, Semra Olgac and Mark Lawrence Heaney. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Biological Chemistry, Blood, Nature Communications and Trends in Biochemical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact